The Journal of Pediatrics
Volume 136, Issue 2 , Pages 168-175 , February 2000

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

Received 14 April 1999 ,Revised 23 August 1999 ,Accepted 9 September 1999.

References 

  1. Glezen WP, Paredes A, Taber LH. Influenza in children: relationship to other respiratory viruses. JAMA. 1980;243:1345–1349
  2. Wright PF, Thompson T, Karzon DT. Differing virulence of H1N1 and H3N2 influenza strains. Am J Epidemiol. 1980;112:814–819
  3. Fox TP, Cooney MK, Hall CE, Foy HM. Influenza virus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol. 1982;116:228–242
  4. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1997;46:1–9
  5. Maassab HF, Heilman CA, Herlocher ML. Cold-adapted influenza viruses for use as live vaccines for man. Adv Biotechnol Process. 1990;14:203–242
  6. Couch RB. Advances in influenza virus vaccine research. Ann New York Acad Sci. 1993;685:803–812
  7. Clancy RL. Mucosal vaccines for the prevention of influenza. Drugs. 1995;50:587–594
  8. Belshe RB. A review of attenuation of influenza viruses by genetic manipulation. Am J Respir Crit Care Med. 1995;152:S72–S75
  9. Maassab HF. Biologic and immunologic characteristics of cold-adapted influenza virus. J Immunol. 1969;102:728–732
  10. Cox NJ, Maassab HF, Kendal AP. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25E between recent H3N2 and H1N1 epidemic strains and cold-adapted A/Ann Arbor/6/10. Virology. 1979;97:190–194
  11. Maassab HF, DeBorde DC. Characterization of an influenza A host range mutant. Virology. 1983;130:342–350
  12. Maassab HF, Kendal AP, Abrams GD, Monto AS. Evaluation of cold-recombinant influenza virus vaccine in ferrets. J Infect Dis. 1982;146:780–790
  13. Donabedian AM, DeBorde DC, Maassab HF. Genetics of cold-adapted B/Ann Arbor/1/66 influenza virus reassortants: the acidic polymerase (PA) protein gene confers temperature sensitivity and attenuated virulence. Microb Pathog. 1987;3:97–108
  14. Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, et al.  The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med. 1998;338:11405–11412
  15. The 1995-96 WHO Influenza Reagent Kit for the Identification of Influenza Isolates [distributed by WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Centers for Disease Control and Prevention]. In: Appendix A. Atlanta (GA): : Centers for Disease Control and Prevention; 1995;p. 15–19
  16. COSTART: coding symbols for thesaurus of adverse reaction terms. 5th ed. Rockville (MD): : Food and Drug Administration; 1995;
  17. SAS, Version 6.12, 1996. Cary (NC): : SAS Institute Inc; 1996;
  18. In: Mathematical statistics. Oakland (CA): : Holden-Day, Inc; 1977;p. 288
  19. Update: influenza activity—United States, 1997-98 season. MMWR Morb Mortal Wkly Rep. 1998;47:36–38
  20. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep. 1998;47:1–26
  21. Update: influenza activity—United States, 1997-98 season. MMWR Morb Mortal Wkly Rep. 1998;47:196–200
  22. Influenza A—Florida and Tennessee, July-August 1998, and virologic surveillance of influenza, May-August 1998. MMWR Morb Mortal Wkly Rep. 1998;47:756–759
  23. Nichol KL, Mendelman PM, Mallon KP, Jackson LA, Gorse GJ, Belshe RB, et al.  Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 1999;282:137–144
  24. Edwards KM, Dupont WD, Westrich MK, Plummer WD, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis. 1994;169:68–76
  25. Wright PF, Karzon DT. Live attenuated influenza vaccines. Prog Med Virol. 1987;34:70–88
  26. Wright PF, Okabe N, McKee KT, Maassab HF, Karzon DT. Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis. 1982;146:71–79

☆ Supported by the National Institutes of Health, Bethesda, Maryland, and Aviron, Mountain View, California.

☆☆ Reprint requests: Robert B. Belshe, MD, Saint Louis University Health Sciences Center, Division of Infectious Diseases, 3635 Vista Ave, FDT-8N, St Louis, MO 63110.

★ 0022-3476/2000/$12.00 + 0  9/21/102916

PII: S0022-3476(00)70097-7

The Journal of Pediatrics
Volume 136, Issue 2 , Pages 168-175 , February 2000

Article Tools

* Image Usage & Resolution